NCT06586151 Testing a Gender-inclusive HIV Prevention Program
| NCT ID | NCT06586151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Center for Innovative Public Health Research |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-09-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.
Eligibility Criteria
Inclusion Criteria: 1. assigned male sex at birth and currently have a non-cisgender identity (e.g., transgender girl, non-binary, gender fluid, unsure); 2. aged 14-18 years and have not yet graduated high school; 3. English-speaking; 4. the sole user of a cell phone with an unlimited text messaging plan; 5. have access to the Internet to complete online surveys; 6. intend to have the same cell number for the next 6 months; 7. provide informed assent; 8. not have taken part in a previous #TranscendentHealth study activity or know someone who is in the study to increase the diversity of input from transgirls, and 9. agree to enroll over the phone with study staff. Exclusion Criteria: * None beyond not meeting inclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06586151 clinical trial?
This trial is open to male participants only, aged 14 Years or older, up to 18 Years, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06586151 currently recruiting?
Yes, NCT06586151 is actively recruiting participants. Contact the research team at michele@innovativepublichealth.org for enrollment information.
Where is the NCT06586151 trial being conducted?
This trial is being conducted at San Clemente, United States.
Who is sponsoring the NCT06586151 clinical trial?
NCT06586151 is sponsored by Center for Innovative Public Health Research. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.